Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Therapy of hormone refractory prostate cancer: new standards, new trends].

Aktuelle Urologie - 1 Aug 2005

Wülfing C, Bierer S, Bögemann M, Piechota H, Hertle L

Abstract excerpt

Hormone-refractory prostate cancer is diagnosed with increasing incidence and has become a growing challenge for urologists. The improved understanding of the tumor biological mechanisms of the hormone-refractory state has led to innovative therapeutic developments in the field of hormonal and cytotoxic therapies. Recently, two large randomized Phase III trials with docetaxel-based chemotherapy were able to show...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Trials, Phase I as Topic
Share to Clinical Trials, Phase II as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clinical Trials, Phase III as Topic

Share to Diphosphonates

Share to Docetaxel

Share to Mitoxantrone

Share to Taxoids

Share to Trastuzumab

Source

Identifiers

PMID: 16110408
DOI: 10.1055/s-2004-830209

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Therapy of hormone refractory prostate cancer: new standards, new trends].PMID 16110408Read ↗

[Recent trend in the development of novel treatments based on the mechanisms of prostate cancer progression].Semantic proximity Read ↗

[Metastatic castration-resistant prostate cancer-emerging trends in therapy].Semantic proximity Read ↗

A retrospective review of combination chemohormonal therapy as initial treatment for locally advanced or metastatic adenocarcinoma of the prostate.Semantic proximity Read ↗

[The mechanism and predictive factors of hormone-independent recurrence of prostate cancer].Semantic proximity Read ↗

[Current situation of researches on the molecule mechanism of hormone refractory prostate cancer].Semantic proximity Read ↗

[Molecular mechanisms involved in hormone resistance of prostate cancer].Semantic proximity Read ↗

State-of-the-art prostate cancer treatment and research. A report from the Cancer Institute of New Jersey.Semantic proximity Read ↗

Prostate cancer treatment – China's perspectiveSemantic proximity Read ↗

Two Steps Forward and One Step Back for Precision in Prostate Cancer Treatment.Semantic proximity Read ↗

Current State of Adjuvant Hormone Therapy in Prostate Cancer and in the Management of Pelvic Nodal Recurrence: A Narrative ReviewSemantic proximity Read ↗

[The Campaign Program for Prostate Integrated Research].Semantic proximity Read ↗

How the Management of Biochemical Recurrence in Prostate Cancer Will be Modified by the Concept of Anticipation and Incrementation of TherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.